Trials / Sponsors / Andrew J. Armstrong, MD
Andrew J. Armstrong, MD
Academic / Other · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Pr Metastatic Prostate Neuroendocrine Carcinoma, Metastatic Prostate Cancer | Phase 2 | 2021-06-07 |
| Completed | A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men Prostate Cancer | Phase 2 | 2018-03-28 |
| Completed | PD-L1 Inhibition as ChecKpoint Immunotherapy for NeuroEndocrine Phenotype Prostate Cancer Prostate Cancer | Phase 2 | 2018-02-01 |
| Completed | The CATCH Prostate Cancer Trial: Cabazitaxel And Tasquinimod in Men With Prostate Cancer Prostate Cancer | Phase 1 | 2012-01-01 |
| Terminated | BKM120 in Metastatic Castration-resistant Prostate Cancer Prostate Cancer, Metastatic (Spread to Other Areas of the Body) | Phase 2 | 2011-08-01 |